Switch theme
Sign up to access all valuation multiples
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company’s ability to develop higher-resolution ECG solutions is achieved through the development of the Company’s proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
2015
21
LTM Revenue $2.5M
Last FY EBITDA -$19.9M
$49.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
HeartBeam has a last 12-month revenue (LTM) of $2.5M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, HeartBeam achieved revenue of n/a and an EBITDA of -$19.9M.
HeartBeam expects next 12-month revenue of XXX and NTM EBITDA of XXX
See HeartBeam valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5M | XXX | n/a | XXX | XXX | XXX |
| Gross Profit | $2.5M | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | n/a | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$19.9M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBIT | -$17.3M | XXX | -$19.9M | XXX | XXX | XXX |
| EBIT Margin | -685% | XXX | n/a | XXX | XXX | XXX |
| Net Profit | -$16.9M | XXX | -$19.4M | XXX | XXX | XXX |
| Net Margin | -671% | XXX | n/a | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, HeartBeam's stock price is $2.
HeartBeam has current market cap of $57.5M, and EV of $49.3M.
See HeartBeam trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $49.3M | $57.5M | XXX | XXX | XXX | XXX | $-0.66 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, HeartBeam has market cap of $57.5M and EV of $49.3M.
HeartBeam's trades at n/a EV/Revenue multiple, and -2.5x EV/EBITDA.
Equity research analysts estimate HeartBeam's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
HeartBeam has a P/E ratio of -3.4x.
See valuation multiples for HeartBeam and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $57.5M | XXX | $57.5M | XXX | XXX | XXX |
| EV (current) | $49.3M | XXX | $49.3M | XXX | XXX | XXX |
| EV/Revenue | 19.5x | XXX | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -2.5x | XXX | XXX | XXX |
| EV/EBIT | -2.9x | XXX | -2.5x | XXX | XXX | XXX |
| EV/Gross Profit | 19.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | -3.4x | XXX | -3.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -3.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHeartBeam's last 12 month revenue growth is 102%
HeartBeam's revenue per employee in the last FY averaged n/a, while opex per employee averaged $0.9M for the same period.
HeartBeam's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
HeartBeam's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for HeartBeam and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 102% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.9M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
HeartBeam acquired XXX companies to date.
Last acquisition by HeartBeam was XXXXXXXX, XXXXX XXXXX XXXXXX . HeartBeam acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was HeartBeam founded? | HeartBeam was founded in 2015. |
| Where is HeartBeam headquartered? | HeartBeam is headquartered in United States of America. |
| How many employees does HeartBeam have? | As of today, HeartBeam has 21 employees. |
| Who is the CEO of HeartBeam? | HeartBeam's CEO is Mr. Robert P. Eno. |
| Is HeartBeam publicy listed? | Yes, HeartBeam is a public company listed on NAS. |
| What is the stock symbol of HeartBeam? | HeartBeam trades under BEAT ticker. |
| When did HeartBeam go public? | HeartBeam went public in 2021. |
| Who are competitors of HeartBeam? | Similar companies to HeartBeam include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of HeartBeam? | HeartBeam's current market cap is $57.5M |
| What is the current revenue of HeartBeam? | HeartBeam's last 12 months revenue is $2.5M. |
| What is the current revenue growth of HeartBeam? | HeartBeam revenue growth (NTM/LTM) is 102%. |
| What is the current EV/Revenue multiple of HeartBeam? | Current revenue multiple of HeartBeam is 19.5x. |
| Is HeartBeam profitable? | Yes, HeartBeam is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
